Sorry, no content matched your criteria.
Featured Story
AstraZeneca (NYSE: AZN) Stock Drops 15% After Rejecting Pfizer
AstraZeneca plc (NYSE: AZN) stock dropped as much as 15% today (Monday) following news that the British pharmaceutical company had rejected Pfizer Inc.'s (NYSE: PFE) final takeover offer.
The fact that a Pfizer AstraZeneca deal was once again rejected upset shareholders, who contributed to AstraZeneca stock's worst one-day performance ever.
AstraZeneca plc (NYSE: AZN) stock dropped as much as 15% today (Monday) following news that the British pharmaceutical company had rejected Pfizer Inc.'s (NYSE: PFE) final takeover offer.
The fact that a Pfizer AstraZeneca deal was once again rejected upset shareholders, who contributed to AstraZeneca stock's worst one-day performance ever.